Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:1.16.3.1 (ceruloplasmin)
 5,074 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Normal human melanocytes, unlike malignant melanoma cells, required at least three growth-promoting agents, i.e., phorbol ester for protein kinase C activation and the growth factors basic fibroblast growth factor (bFGF) and insulin, for growth in chemically defined W489 medium. Cell growth was further stimulated by addition of agents that increase intracellular levels of cyclic adenosine 3',5'-monophosphate (cAMP) to the medium. Among these agents, the pituitary hormones alpha-melanocyte-stimulating hormone (alpha-MSH) and follicle-stimulating hormone were the most potent, whereas bacterial toxins, including cholera, tetanus, and pertussis toxin and their subunits either were less mitogenic or gave variable results depending on the culture tested. Medium containing phorbol ester PMA, growth factors bFGF and insulin (or insulin-like growth factor-I), and synthetic alpha-MSH supported melanocyte growth for more than 5 months with doubling times between 5 and 8 days. Two copper-binding proteins, ceruloplasmin and tyrosinase, were mitogenic when added to medium and ceruloplasmic induced a long bi- to tripolar-shape of cells. Addition of 1 mM dibutyryl cAMP to the medium led to the formation of dendrites in all cells, with an average of 28 extensions per cell. Although cell growth was inhibited by dibutyryl cAMP, cells were not terminally differentiated and continued to proliferate. Dendritic melanocytes showed a 2.2-fold increase in activity of the tyrosine kinase pp60c-src. The induction of dendritic processes in melanocytes by dibutyryl cAMP or sodium butyrate was reversible and appears to reflect the expression of the mature melanocytic phenotype in situ.
 ...
PMID:Regulatory factors that determine growth and phenotype of normal human melanocytes. 246 9

This paper reviews the immunomodulatory effects, extra-pituitary expression and paracrine action of growth hormone (GH), and a possible role of GH/insulin-like growth factor-I (IGF-I) axis in the immune system of teleost fish. In some euryhaline fish, the activation of immune functions observed during seawater acclimation appears to be associated with the osmoregulatory action of GH. Administration of GH enhances many aspects of immune functions including non-specific defences; cytotoxic, phagocytic, haemolytic and lysozyme activities. GH also activates immunoglobulin production as a specific defense and increases ceruloplasmin levels as an acute-phase protein. The GH gene is also expressed in many extra-pituitary tissues of fish, especially in lymphoid organs and cells. Several endocrine factors appear to act on immune function through modification of GH secretion from fish leucocytes. Exposure of phagocytic leucocytes of tilapia to IGF-I in vitro stimulated proliferation and superoxide production associated with phagocytosis. Exposure to GH had no significant effect on IGF-I secretion from tilapia leucocytes, despite of the fact that they secreted significant amounts of IGF-I. GH and IGF-I appear to act in a paracrine manner in the regulation of the teleostean immune system. Further studies are necessary to characterize the interactions of GH with other endocrine and paracrine factors.
 ...
PMID:Growth hormone and fish immune system. 1738 28

In-vitro effects of insulin-like growth factor-I (IGF-I) on superoxide production in phagocytic head kidney leucocytes (HKL) and in-vivo effects on plasma lysozyme levels were examined in the rainbow trout (Oncorhynchus mykiss). In-vitro administration of salmon IGF-I (sIGF-I), human IGF-I, and human IGF-II Increased superoxide production in zymosan-stimulated HKL. A significant effect of sIGF-I on superoxide production in HKL was observed from 0.1 to 100 nM, and was equipotent to that of salmon growth hormone. IGF receptor (IGFR) type Ib was expressed in trout HKL, and also In the brain, pituitary, liver, and gills; however, the expression of another IGFR (type Ia) was not detected in HKL. In-vivo intraperitoneal injection of sIGF-I Increased plasma levels of lysozyme, whereas ceruloplasmin or immunoglobulin M did not change. These results Indicate that IGF-I stimulates non-specific immune functions In fish.
 ...
PMID:Effects of insulin-like growth factor-I on non-specific immune functions in rainbow trout. 1971 3